CAIRO: The treatment of 15,000 patients with Hepatitis C virus using the new regimen of the locally-manufactured drugs has kicked off, according to the Health Ministry.
Tamer Hamed, head of the specialized medical councils at the ministry told Youm7 Saturday that treatment protocol includes the Egyptian-made Sovaldi and the imported Daklinza together.
A total of seven new medical centers and three others belong to military hospitals will be opened for Hepatitis C patients to receive the medication and for full examination, Hamed said.
He noted that more than 5,500 patients have received the new regimen thus far.
In 2016, the ministry hopes to cure a total of 500,000 Hepatitis C patients across Egypt using the Egypt-made regimen, which will include the locally-produced Daklinza medicine, according to Thursday statements by Deputy Head of National Committee to Combat Hepatitis Viruses Waheed Dous to Youm7.
Egypt has one of the highest infection rates of Hepatitis C in the world. The country has imported Hepatitis C medicines from the U.S. since 2014, and recently began to locally produce them at subsidized costs.
The Egyptian Sovaldi will be available at less than 680 EGP ($80) per bottle at liver centers, and will be priced at 1,200 EGP/bottle at pharmacies, according to a previous announcement by the Health Ministry.
Additional reporting by Waleed Abdel Salam.